Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
JD HEALTH
06618
5
BIDU-SW
09888
| (Q2)Sep 30, 2025 | (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q4)Mar 31, 2025 | (Q3)Dec 31, 2024 | (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -25.52%175.83M | -18.67%179.7M | -9.15%822.78M | -13.45%179.58M | -20.28%186.18M | -0.15%236.07M | -3.19%220.96M | -8.67%905.69M | 6.11%207.48M | -10.03%233.55M |
| Cost of revenue | -6.76%714.61M | -12.35%766.42M | ||||||||
| Gross profit | -22.33%108.17M | 18.78%139.27M | ||||||||
| Operating expense | -28.94%170.55M | -15.16%176.56M | 32.39%87.9M | -9.29%178.99M | -19.15%175.5M | 17.74%240M | -2.99%208.1M | 36.02%66.39M | 129.06%197.33M | -9.00%217.07M |
| Selling and administrative expenses | ---- | ---- | -5.87%79.17M | ---- | ---- | ---- | ---- | 5.47%84.11M | ---- | ---- |
| -Selling and marketing expense | ---- | ---- | -5.88%41.58M | ---- | ---- | ---- | ---- | 9.42%44.18M | ---- | ---- |
| -General and administrative expense | ---- | ---- | -5.86%37.59M | ---- | ---- | ---- | ---- | 1.43%39.93M | ---- | ---- |
| Other operating expenses | -28.78%171.87M | -15.06%177.8M | 180.66%14.19M | -10.49%180.51M | -15.54%184.67M | 10.91%241.33M | -5.26%209.34M | -58.55%5.06M | 126.72%201.67M | -13.34%218.66M |
| Total other operating income | -1.12%1.32M | 0.89%1.25M | -76.00%5.46M | -65.05%1.52M | 477.93%9.17M | -90.29%1.34M | -80.83%1.23M | -47.21%22.77M | 9.38%4.34M | -88.49%1.59M |
| Operating profit | 234.56%5.28M | -75.59%3.14M | -72.18%20.27M | -94.24%584K | -35.21%10.67M | -112.05%-3.93M | -6.34%12.85M | 6.49%72.87M | 11,977.38%10.15M | -21.66%16.47M |
| Net non-operating interest income (expenses) | -15.74%4.52M | -12.19%4.54M | -4.24%20.02M | -12.90%4.69M | -8.36%4.79M | 0.47%5.37M | 4.45%5.17M | 53.72%20.91M | 10.82%5.39M | 35.58%5.23M |
| Non-operating interest income | -15.55%4.53M | -11.98%4.55M | -4.10%20.05M | -12.69%4.71M | -7.98%4.81M | 0.45%5.37M | 4.45%5.17M | 53.69%20.91M | 10.82%5.39M | 35.55%5.23M |
| Non-operating interest expense | --10K | --11K | 3,000.00%31K | --11K | --20K | --0 | --0 | -66.67%1K | --0 | --0 |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | -96.27%22K | 1,700.00%144K | 254.39%88K | 112.68%130K | -136.86%-623K | 216.83%590K | 95.85%-9K | -57K | -1.03M | 2,540.63%1.69M |
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | -50.48%1.29M | -64.24%958K | -9.91%11.6M | -41.47%3.48M | 937.57%2.83M | -16.75%2.61M | -35.15%2.68M | 38.41%12.88M | 622.45%5.95M | 83.74%-338K |
| Special income (charges) | ||||||||||
| Other non-operating income (expenses) | ||||||||||
| Income before tax | 139.74%11.12M | -57.58%8.78M | -51.34%51.89M | -56.54%8.89M | -23.34%17.67M | -88.56%4.64M | -8.39%20.69M | 16.77%106.66M | 249.06%20.46M | 0.80%23.05M |
| Income tax | -58.45%902K | -66.39%974K | -58.91%5.76M | -95.24%137K | -66.34%551K | -70.39%2.17M | 34.10%2.9M | 25.03%14.01M | 293.42%2.88M | -60.52%1.64M |
| Net income | 314.15%10.22M | -56.15%7.8M | -50.20%46.14M | -50.20%8.76M | -20.05%17.12M | -92.57%2.47M | -12.88%17.79M | 15.62%92.65M | 139.18%17.58M | 14.38%21.42M |
| Net income continuous operations | 314.15%10.22M | -56.15%7.8M | -50.20%46.14M | -50.20%8.76M | -20.05%17.12M | -92.57%2.47M | -12.88%17.79M | 15.62%92.65M | 139.18%17.58M | 14.38%21.42M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 314.15%10.22M | -56.15%7.8M | -50.20%46.14M | -50.20%8.76M | -20.05%17.12M | -92.57%2.47M | -12.88%17.79M | 15.62%92.65M | 139.18%17.58M | 14.38%21.42M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 314.15%10.22M | -56.15%7.8M | -50.20%46.14M | -50.20%8.76M | -20.05%17.12M | -92.57%2.47M | -12.88%17.79M | 15.62%92.65M | 139.18%17.58M | 14.38%21.42M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 325.00%0.17 | -55.17%0.13 | -50.33%0.76 | -48.28%0.15 | -22.22%0.28 | -92.59%0.04 | -14.71%0.29 | 15.91%1.53 | 141.67%0.29 | 16.13%0.36 |
| Diluted earnings per share | 325.00%0.17 | -55.17%0.13 | -50.33%0.76 | -48.28%0.15 | -22.22%0.28 | -92.59%0.04 | -14.71%0.29 | 15.91%1.53 | 141.67%0.29 | 16.13%0.36 |
| Dividend per share | -61.16%0.47 | 0 | 11.48%1.36 | 0 | 0.00%0.15 | 13.08%1.21 | 0 | 46.99%1.22 | 0 | 0.00%0.15 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.